School of Medicine
Showing 1,881-1,900 of 13,032 Results
-
Hannah Cheng
Soc Science Rsch Asst 3, Psych/Public Mental Health & Population Sciences
BioHannah Cheng, MS is a Research Scientist at the Stanford Center for Dissemination and Implementation. Her overarching goal is to leverage implementation science to dismantle systemic barriers and improve access to behavioral health services. Her work focuses on identifying strategies to implement innovations in resource-limited settings and integrating economic evaluations in implementation research to maximize return on investment
-
Jordan C. Cheng, DMD, PhD
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy research direction involves the evalutation of single-stranded library prepartion methods versus conventional double-stranded methods of cell-free DNA for non-invasive cancer profiling applications. The exploration of these technologies allow for the inference of the genomic and epigenetic features of both local and distant cell types associated with a biofluid.
-
Paul Cheng MD PhD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Cheng is a Cardiologist at Stanford University School of Medicine in the Department of Medicine and a member of the Cardiovascular Research Institute. Dr. Cheng received his BEng in Chemical Engineering and BSc in biology at MIT. He subsequently completed his MD/PhD at UCSF working in the Srivastava lab studying how extracellular morphogenic signals affect cardiac development and fate determination of cardiac progenitors. Dr. Cheng completed internal medicine residency and cardiology fellowship at Stanford, including a post-doctoral training in the Quertermous lab. His current clinical focus is in amyloidosis and cardio-oncology.
Dr. Cheng pioneered the application of single cell transcriptomic and epigenetic techniques to study human vascular diseases including atherosclerosis and aneurysm, and applied these techniques to investigate molecular mechanisms behind genetic risk factors for several human vascular diseases including atherosclerosis, and aortopathies such as Marfan's and Loey-Dietz syndrome. The Cheng lab takes a patient-to-bench-to-bedside approach to science. The lab focuses on elucidating new pathogenic mechanisms of human vascular diseases through combing human genetics and primary vascular disease tissues, with high-resolution transcriptomic and epigenetic profiling to generate novel hypothesis that are then tested in a variety of in vitro and in vivo models. The lab is focused on two broad questions: (1) understanding the biological underpinning of the differences in diseases propensities of different arterial segments in an individual (i.e. why do you have atherosclerosis and aneurysms in certain segments but not others), and (2) understanding the role of perivascular fibroblast in human vascular diseases.
Find out more about what the Cheng lab is up to, check out https://chenglab.stanford.edu -
Tiffany Cheng
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioI am a physician leader and anesthesiologist at Stanford Health Care, where I serve as Medical Director of Perioperative Services at SHC Palo Alto and hold a faculty appointment as Clinical Assistant Professor at Stanford University School of Medicine.
My work sits at the intersection of direct patient care and systems-level leadership. I have a track record of building high-performing clinical teams, designing governance structures from the ground up, and delivering measurable operational impact — including significant improvements in OR utilization, block efficiency, and access to care across Stanford's interventional platform.
I founded Stanford's Anesthesiology Mentorship Program (AMP), a faculty development initiative that received the Augustus A. White III Award, and co-founded ASPIRE, a multi-institutional speaker exchange network. I am a graduate of Stanford's Physician Leadership Certificate Program and will begin an Executive MBA at Santa Clara University in Fall 2026.
I believe that the strongest clinical institutions are built on trust, accountability, and a genuine investment in the people doing the work — and I bring that conviction to every leadership role I hold. -
Xingxing Shelley Cheng
Assistant Professor of Medicine (Nephrology) and, by courtesy, of Surgery (Abdominal Transplantation) and of Health Policy
Current Research and Scholarly InterestsDr. Xingxing Cheng's expertise is in applying the tools of decision science to clinical practice and policy analysis. Her current research is in the following areas:
1) the costs, effectiveness, and implementation of work-up before kidney transplantation, including pretransplant cardiovascular screening;
2) ethics of and decision-making in in multi-organ transplantation. -
Mathieu Chenier
MD Student with Scholarly Concentration in Bioengineering / Cardiovascular-Pulmonary Sciences, expected graduation Spring 2029
Bio• Current MD/PSTP student
• Studied biomedical engineering and engineering physics at McMaster University in Hamilton, Ontario, between 2019-2024
• Interested in pediatric medicine, bioengineering, and engineering in medicine
• From Belle River, Ontario -
Annie Bertha Chao
Clinical Assistant Professor (Affiliated), Medicine - Primary Care and Population Health
Staff, Medicine - Primary Care and Population HealthBioDr. Annie Chern grew up in Wichita, Kansas, and remains a Midwestern girl at heart. After attending Washington University in St. Louis for her undergraduate degree, she received her M.D. from Stanford University School of Medicine. She has a special interest in helping patients of all ages with weight management, obesity prevention, and chronic disease care.
Dr. Chern has volunteered her time as a physician at Arbor and Pacific Free Clinics, the two Stanford-associated free clinics that provide basic healthcare for underserved patients. In her leisure time, she enjoys running in all forms - most of all - chasing after her fleet-footed twin toddlers!
